June 14, 2013 (Newswise) — The new weight loss drug lorcaserin (Belviq) appears to improve blood sugar control in nondiabetic, overweight individuals, independent of the amount of weight they lose, a new study finds. The results will be presented Saturday at The Endocrine Society's 95th Annual Meeting in San Francisc

Continue reading "Weight Loss Drug Added to Diet and Exercise Improves Blood Sugar Control"

June 16, 2013 (Newswise) — Overweight women who skip breakfast experience acute, or rapid-onset, insulin resistance, a condition that, when chronic, is a risk factor for diabetes, a new study finds. The results, which were presented Sunday at The Endocrine Society's 95th Annual Meeting in San Francisco, suggest that regularly skipp

Continue reading "Skipping Breakfast May Make Obese Women Insulin Resistant"

June 14, 2013 (Newswise) — Reduced effectiveness of the hormone insulin, or insulin resistance, is associated with weakened bones, a clinical study shows. The results were presented Sunday at The Endocrine Society's 95th Annual Meeting in San Francisco.

In the United States, the incidence of diabetes is quickly mounting. Between the years

Continue reading "Insulin Resistance Linked to Weaker Bones"

June 18, 2013 (Newswise) — A drug that mimics the activity of thyroid hormone significantly increases the amount of energy burned by fat tissue and promotes weight loss, an animal study of metabolism finds. The results were presented Sunday at The Endocrine Society's 95th Annual Meeting in San Francisco.

Humans and other mamma

Continue reading "Drug Boosts Fat Tissue’s Calorie-Burning Ability in Lab"

June 6, 2013 (Newswise) — Researchers from the Icahn School of Medicine at Mount Sinai will present several new studies at ENDO 2013, The Endocrine Society's Annual Meeting & Expo (ENDO) from June 15-18 in San Francisco.

Mount Sinai researchers will demonstrate new da

Continue reading "Individuals with Diabetes Who Use Meters to Monitor Their Glucose Levels Have Better Control Over Their Disease"